A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

NCT05622890 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Epithelial Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer

Interventions

DRUG: Mirvetuximab Soravtansine

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.